Prediction of infection after total knee arthroplasty in rheumatoid arthritis patients by evaluating various risk factor
Abstract
Introduction: Total knee arthroplasty (TKA) is a surgical procedure that provides pain relief and restores function for patients suffering from debilitating arthritis. Despite the overall success of the procedure, periprosthetic joint infection (PJI) is a rare but devastating complication andfound to be a major cause of TKA failure.An infected implant often requires removal, prolonged immobilization and antibiotic treatment and multistage surgery. Hence, prevention of infections in intraoperative and postoperative stage is of paramount importance.
Material and method: We have conducted a retrospective study in SreeSudheendra Medical Mission hospital, Ernakulum, Kerala. We collected the data from April 2014 to March 2018. In this duration we have found 89 cases of rheumatoid arthritis underwent TKA in 148 knees. We have collected and analysed demographic data and information regarding risk factors [like ESR, H/O Diabeties, steroid intake, blood transfusion, preop deformity, preop DMARDs, intraop soft tissue manipulation/finding, Albumin Globulin ratio (A/G)] associate with infection. Postoperatively we have followed our patient for the minimum period of 9 months period to 4 years.
Result: We identified DMARDs (esp. methotraxate) and intraoperative manipulation like bone grafting, extra soft tissue release, Z-plasty of tendon as a risk factor for superficial periprosthetic infection (P value <0.05). Diabetes, use of Steroid, Age, Anemia, Blood Transfusion, B/L surgery are not a risk factor for infection (P value > 0.05).
Conclusion: These results guide our understanding of the relationship between infections and TKA in RA patient, and may help to prospectively identifyinghigh-risk patients, facilitating extra vigilance and implementation of preventive strategies in such patients.
Downloads
References
2. Maier GS, Horas K, Seeger JB, et al. Is there an association between periprosthetic joint infection and low vitamin D levels? Int Orthop. 2014 Jul;38(7):1499-504. doi: 10.1007/s00264-014-2338-6. Epub 2014 Apr 16. [pubmed]
3. Baek SH. Identification and preoperative optimization of risk factors to prevent periprosthetic joint infection. World J Orthop. 2014 Jul 18;5(3):362-7. doi: 10.5312/wjo.v5.i3.362. eCollection 2014 Jul 18.[pubmed]
4. Talbot TR, Kaiser AB. Post-operative infections and antimicrobial prophylaxis. In: Mandell GL, Bennett JE, Dolin R,editors. Principles and Practice of Infectious Diseases, 6thedn. Philadelphia: Churchill Livingstone; 2005. p. 3533 _47.
5. Schwartz T, Agassi M, Peled T. (2000). Prevalence survey ofnosocomial infections in Israeli general hospitals (1997 -1998) (Hebrew). Israeli Ministry of Health Report No.4003.
6. Larcom P, Lotke PA. Treatment of inflammatory and degenerative conditions of the knee. In: Dee R, editor. Principles of Orthopedic Practice. New York: McGraw-Hill Company; 1997. p. 975 _7.
7. Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect. 2001 Oct;49(2):87-93.[pubmed]
8. Lidwell OM. Sir John Charnley, surgeon (1911-82): the control of infection after total joint replacement. J Hosp Infect. 1993 Jan;23(1):5-15.[pubmed]
9. Phillips J, Crane T, Noy M. The incidence of deep prosthetic infections in a specialist orthopaedic hospital a15-year prospective survey. J Bone Joint Surg Br 2006; 88:943-948.
10. Blom AW, Brown J, Taylor AH, et al. Infection after total knee arthroplasty. J Bone Joint Surg Br. 2004 Jul;86(5):688-91.[pubmed]
11. Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin OrthopRelat Res. 2001 Nov;(392):15-23.[pubmed]
12. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.[pubmed]
13. J A Rand et al. Long-term results of various treatment options for infected total knee arthroplasty. Clinical orthopaedics and related research 248 (1989): 120-128
14. Parvizi J, Adeli B, Zmistowski B, et al. Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am. 2012 Jul 18;94(14):e104. doi: 10.2106/JBJS.K.01417.[pubmed]
15. Scott JD, Forrest A, Feuerstein S, et al. Factors associated with postoperative infection. Infect Control Hosp Epidemiol. 2001 Jun;22(6):347-51.[pubmed]
16. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998 Nov;27(5):1247-54.[pubmed]
17. Parvizi J, Ghanem E, Joshi A, et al. Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007 Sep;22(6 Suppl 2):24-8. Epub 2007 Jul 26.[pubmed]
18. Lai K, Bohm ER, Burnell C, et al. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty. 2007 Aug;22(5):651-6. DOI:10.1016/j.arth.2006.09.002.[pubmed]
19. Minnema B, Vearncombe M, Augustin A, et al. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol. 2004 Jun; 25(6):477-80.[pubmed]
20. Jämsen E, Nevalainen P, Kalliovalkama J, et al. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010 Jun;21(3):196-201. doi: 10.1016/j.ejim.2010.02.006. Epub 2010 Mar 15.[pubmed]
21. Edmonston DL, Foulkes GD. Infection rate and risk factor analysis in an orthopaedic ambulatory surgical center. J SurgOrthop Adv. 2010 Fall;19(3):174-6.[pubmed]
22. Meding JB, Reddleman K, Keating ME, et al. Total knee replacement in patients with diabetes mellitus. Clin OrthopRelat Res. 2003 Nov;(416):208-16. DOI:10.1097/01.blo.0000093002.90435.56.[pubmed]
23. Meding JB, Klay M, Healy A. The pre screening history and physical in elective total joint arthroplasty. J Arthroplast2007; 22: 21-23.[pubmed]
24. Papagelopoulos PJ, Idusuyi OB, Wallrichs SL. Long term outcome and survivorship analysis of primary total knee arthroplasty in patients with diabetes mellitus. Clin OrthopRelat Res 1996; 330: 124-132.[pubmed]
25. Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty. 2001 Jan;16(1):102-6. DOI:10.1054/arth.2001.19159.[pubmed]
26. England SP, Stern SH, Insall JN, et al. Total knee arthroplasty in diabetes mellitus. Clin OrthopRelat Res. 1990 Nov;(260):130-4.[pubmed]
27. Syahrizal A, Kareem B, Anbanadan S. Risk factors for infection in total knee replacement surgery at hospital Kuala Lumpur. Med J Malay 2001; 56: 5-8.
28. Robert A. Malinzak, MD, Merrill A. Ritter, MD, Michael E. Berend, MD, John B. Meding, MD, Emily M. Olberding, MD, and Kenneth E. Davis, MS. Morbidly Obese, Diabetic, Younger, and Unilateral Joint Arthroplasty Patients Have Elevated Total Joint Arthroplasty Infection Rates. The Journal of Arthroplasty Vol. 24 No. 6 Suppl. 1 2009.
29. Ritter MA, Harty LD, Davis KE, et al. Simultaneous bilateral, staged bilateral, and unilateral total knee arthroplasty. A survival analysis. J Bone Joint Surg Am. 2003 Aug;85-A(8):1532-7.[pubmed]
30. Greenky M, Gandhi K, Pulido L, et al. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin OrthopRelat Res. 2012 Oct;470(10):2695-701. doi: 10.1007/s11999-012-2435-z.[pubmed]
31. Pulido L, Ghanem E, Joshi A, et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin OrthopRelat Res. 2008 Jul;466(7):1710-5. doi: 10.1007/s11999-008-0209-4. Epub 2008 Apr 18.[pubmed]
32. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005 Jan;127(1):295-307. DOI:10.1378/chest.127.1.295.[pubmed]
OAI - Open Archives Initiative
Therapoid
